Information For Authors
- Author Benefits Program
- Manuscript Submission Guidelines
- Open Access Policy
- NIH/HHMI Wellcome Trust Policies
- Self-Archiving Policy
HIGH ALTITUDE MEDICINE & BIOLOGY is a quarterly peer-reviewed journal that publishes original research papers, review papers, and short communications. Contributions are welcome in the fields of high altitude diseases and other high altitude life sciences, including physiology, pathology, comparative biology, anthropology, evolutionary biology, and human and animal ecology. The journal has a strong interdisciplinary coverage.
All new manuscripts must be submitted online at
Copyright Agreement Form
Manuscripts should be submitted with the understanding that they have neither been published, nor are under consideration for publication elsewhere, except in the form of an abstract. Prior abstract publications should be described in the form of a footnote to the title. Published manuscripts become the sole property of the Journal and will be copyrighted by Mary Ann Liebert, Inc. By submitting a manuscript to the Journal, the author(s) agree(s) to each of the above conditions. In addition, the author(s) explicitly assign(s) any copyrighted ownership he/she (they) may have in such manuscript to the Journal.
Upon acceptance of any manuscript, all authors will receive a follow-up email with instructions on how to complete our online Copyright Agreement form. It is critical to ensure the accuracy of ALL authors’ email addresses when uploading submissions to Manuscript Central to ensure the proper delivery of all email communications.
FAILURE BY ALL AUTHORS TO SUBMIT THIS FORM MAY RESULT IN A DELAY OF PUBLICATION.
The corresponding author is responsible for communicating with coauthors to make sure they have completed the online copyright form. Authors not permitted to release copyright must still return the form acknowledging the statement of the reason for not releasing the copyright.
Prepare the entire manuscript including references, tables, and figure legends double-spaced with one-inch margins on all sides.
On the first page, give the title of the paper, full name(s) of all author(s), institutional affiliation(s), and the name (with complete address, phone and fax numbers, and e-mail address) to whom correspondence should be directed. We require the full mailing address and contact information (telephone, fax, and e-mail address) for EACH author listed on your paper. Please also indicate the corresponding author. Supply a running title of no more than 40 characters (including spaces). On the second page, supply an abstract of about 200 words, stating the aims, results, and conclusions drawn from the study and 5-6 key words to help with indexing. You will also be asked to enter the abstract and keywords online during the submission process.
This should be followed by the introduction, materials and methods, results, discussion, conclusion, disclosure statement, acknowledgments, references, tables, figure legends, and figures.
Results and discussion should be separate sections. Number pages consecutively; the first author's last name should appear on each page. Authors should review the style and clarity of their manuscripts with colleagues before submission. Please follow the protocol described herein to avoid delay in publication. Authors should note that manuscripts may be edited if needed to ensure clear grammatical English usage.
All papers will be sent to two or more expert reviewers for their opinions. The editor welcomes suggestions concerning potential reviewers. You will have the opportunity to suggest reviewers during the online submission process, however, reviewer selection is at the discretion of the Editor. A valid email address for suggested reviewers is required.
Studies involving human subjects or experimental animals should explicitly state that the protocols were reviewed by the appropriate institutional review committees and that, in the case of human subjects, informed consent was obtained. Any possible financial conflicts of interest, for example in drug studies, should be disclosed.
Brief Reports and Letters to the Editor
Submission of Brief Reports is also welcome. A Brief Report should communicate new scientific or methodological information in the field of high altitude medicine and biology. It should be divided as follows: abstract (no more than 200 words), introduction, materials and methods, results and discussion (please note that in Brief Reports, results and discussion can be fused), acknowledgments, references, tables, figure legends, and figures. The whole report should be composed of no more than four journal pages (about 3,000 words), including tables and figures. Letters to the Editor are also welcome but with a 500 word limit and no more than one table OR one figure, and with a maximum of four references.
Tables and Illustrations
Prepare each table with its title in a separate file. Use Arabic numerals to number tables. Do not repeat information that is given in the text, and do not make a table for data that can be given in the text in one or two sentences.
Please submit artwork according to the following guidelines:
• Do NOT include any illustrations as part of your text file.
• Do NOT prepare any figures in Word as they are not workable.
• Line illustrations must be submitted at 1200 DPI.
• Halftones and color photos should be submitted at 300 DPI.
• Please submit only TIFF or EPS files.
• Color art must be saved as CYMK not RGB or INDEX. If RGB files are submitted, the files will be converted
to CYMK, and some slight color variation may occur.
• Do NOT submit PowerPoint or Excel files. Adobe is the software of choice.
Please name your artwork files with the submitting authors name i.e. SmithFig1.tif, SmithTable2.tif etc. Authors who do not follow these guidelines may have their submission returned to them without being reviewed.
You will be given directions on how to correct any files which do not pass.
ADDITIONAL INFORMATION ABOUT ART FILES
Converting Word or Excel files: Perhaps the best and easiest way to convert Word or Excel files into a format which is suitable for print is to scan them using the below guidelines:
- All files should be scanned at 100% size.
- 300 dpi
- Final color mode: cmyk
- save file as: .tif or .eps
If you need directions on how to convert a Power Point slide to acceptable format go to https://home.liebertpub.com/MEDIA/pdf/ppconvert.pdf
All authors are expected to disclose any institutional or commercial affiliations that might pose a conflict of interest regarding the publication of a manuscript. Institutional affiliations, as indicated on the title page, should include all corporate affiliations and any funding sources that support the work. Other types of affiliation, including consultantships, honoraria, stock ownership, equity interests, arrangements regarding patents, or other vested interests should be disclosed in the Acknowledgments section.
All references should be cited by author(s) and dates within the text [i.e., In some studies, REM sleep is virtually abolished at high altitude (Pappenheimer, 1977)]. If more than two authors are involved, use et al. after the first author's name [i.e., (Lahiri et al., 1999)]. If more than one paper by the same author(s) and year is cited in the text, use a lower case letter designation to indicate the individual paper [i.e., (Smith, 1984a)]. Use the same designation in the reference list.
The reference list should be double-spaced and listed in alphabetical order at the end of the paper. Each reference should include a complete list of authors and the complete title of the cited paper, as follows:
Journal citation: Lahiri S, Smatresk N, Pokorski M, Barnard P, Mokashi A, and McGregor KH (1984). Dopaminergic efferent inhibition of carotid body chemoreceptors in chronically hypoxic cats. Am J Physiol 247:R24-R28.
Chapter in an edited book: Weil JV, Kryger MH, and Scoggin CH (1978). Sleep and breathing at high altitude. In: Sleep Apnea Syndromes. C Guilleminault and W Dement, eds. Liss, New York; pp. 119-136.
Entire book: Barcroft J (1925). The Respiratory Function of the Blood. Part I: Lessons from High Altitude. Cambridge University Press, Cambridge, UK.
If work is in press, give the journal in which it is to be published. Abbreviations of journal names should follow the style of Medline.
The author must obtain permission whenever it is required in conjunction with the reproduction of material such as figures and tables from copyrighted material. Written permission must be obtained (by the author) from the publisher of the journal or book concerned. The publication from which the figure or table is taken must be listed in the reference list. Finally, a footnote of a reprinted table, or of the legend of a reprinted figure should read "reprinted by permission from Jones et al. (1991)" and the appropriate reference should be cited in the reference list. All permission listings must be shown in the manuscript; they cannot be entered on proofs.
Manuscripts submitted to this journal must not be under consideration elsewhere.
Reprints may be ordered by following the special instructions that will accompany page proofs, and should be ordered at the time the corresponding author returns the corrected page proofs to the Publisher. Reprints ordered after an issue is printed will be charged at a substantially higher rate.
Ensure maximum visibility, discoverability, and impact for your article with our Liebert Open Access (OA) option
Does your research funder have an open access mandate or would you like to expand the dissemination of your research?
The Liebert Open Access option enables authors to publish open access in our esteemed subscription-based journals.
The benefits of Liebert Open Access include:
- High visibility; open access articles are freely available online upon publication
- You retain copyright with the open access license allowing broad dissemination of your research
- You can freely share your article in repositories and research networks without restrictions
- Easy compliance with open access mandates
- Rigorous editorial and peer-review
- Targeted email announcement featuring a direct link to article
Identification and Marketing
Open access articles are listed with an OA icon in journal tables of content (TOC), TOC alerts, and in marketing announcements. Open access articles are highlighted and promoted in targeted email announcements to thousands of research leaders in your field.
Copyright and Licensing
If you choose to publish with open access, you will retain copyright of your article and a Creative Commons license will be applied. The liberal Creative Commons Attribution 4.0 (CC-BY) license is the default open access license used at Mary Ann Liebert, Inc., publishers. The CC-BY license permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited.
Ordering Open Access
Once your article has been accepted for publication in a journal, you will receive an email with information on ordering Liebert Open Access. If you would like more information about Liebert Open Access or would like to order open access, please email firstname.lastname@example.org.
Publishing open access includes an article publication charge (APC) and authors are asked to fill out a short open access order form. You can pay by credit card or receive an invoice to be returned with payment or via bank transfer. Please remember that traditional subscription journals can carry mandatory or optional author fees. The Liebert Open Access APC does not cover or replace existing publication or author fees.
Publishing biomedical or biotechnology research?
Biomedical researchers should consider publishing in BioResearch Open Access, a fully open access peer-reviewed journal dedicated to publishing top research in the biomedical and biotechnology fields. For details, please visit the information for authors on the journal website.
*Please note that PubMedCentral, not the Publisher, has sole control over when the paper is made live on PMC.
Browse journals in the Liebert Open Access portfolio:
NIH Public Access Policy: In order to assist our authors who have NIH funding to comply with this policy, Mary Ann Liebert, Inc. publishers will deposit the final accepted paper (after copy-editing and proofreading) to PubMed Central (PMC) on behalf of the authors. Authors need not take any action. The manuscript's public access posting on PMC will occur 12 months after final publication. This service is provided free of charge. Please note that authors may not deposit manuscripts directly to PMC or other sites without permission from Mary Ann Liebert, Inc.
Publishing in Subscription Journals
By signing the copyright transfer statement, authors still retain a set of rights that allow for self-archiving.
Authors may archive their preprint manuscripts (version prior to peer review) at any time without restrictions. Authors may archive their postprint manuscripts (accepted version after peer review) in institutional repositories, preprint servers, and research networks after a 12 month embargo. The 12 month embargo period begins when the article is published online. Postprints must not be used for commercial purposes and acknowledgement must be given to the final publication, and publisher, by inserting the DOI number of the article in the following sentence: “Final publication is available from Mary Ann Liebert, Inc., publishers http://dx.doi.org/[insert DOI]”. Authors may archive on their personal website without an embargo provided their manuscript is updated with an acknowledgement to the publisher copyright and final published version.
The final published article (version of record) can never be archived in a repository, preprint server, or research network.
Publishing Open Access
Authors that wish to easily comply with funder or institutional open access mandates should consider publishing open access. Liebert Open Access option allows authors to make their research freely available online without restrictions. Additionally, Liebert Open Access option allows authors to retain copyright, archive and share the final published version of their article without restrictions. To publish open access please email email@example.com or visit Liebert Open Access for more information.